A group of researchers whose work has been under investigation at the University of Louisville has issued a correction for a paper in the American Journal of Respiratory Cell and Molecular Biology (AJRCMB).
We have an update in the case of two Japanese scientists who first came to our attention when they retracted a 13-year-old paper in the Journal of Neuroscience last year. Shortly after that, we learned, thanks to a report in Sankei Shimbun and a helpful Retraction Watch reader, that some 17 papers were being investigated.
It now appears that 19 papers by the two researchers, Kenji Okajima and Naoki Harada, ended up under scrutiny.
Nagoya City University said last week that their investigation had concluded that Okajima and Harada committed misconduct. The university dismissed Harada, whom they found guilty of misconduct in at least eight of the papers. The investigation couldn’t find any evidence that Okajima was directly involved, but suspended him for six months because he supervised the work. Continue reading Japanese universities find pair of researchers guilty of misconduct in 19 papers
Plagiarism is a frequent reason for retraction. Today, we’re pleased to present a guest post by Marya Zilberberg, a physician health services researcher and faculty member at the University of Massachusetts at Amherst School of Public Health and Health Sciences. In this post, she describes what it’s like to find out one of your papers has been plagiarized — and how to get satisfaction. Well, sort of.
Right or wrong, peer-reviewed publications in my trade are academic currency. They provide name recognition, invitations to review, edit and speak, and in general make you feel like a part of the “in-crowd.” Of course the most important metric that publications feed are the infamous h-index, which measures how “influential” your studies are by the number of citations they engender. So, like any other artificial grade, it makes sense to engage in intermittent care and watering of your h-index, and mine is pretty good for where I am in my career. Little did I realize that there is an even more important impact metric than the h-index: plagiarism.
One of the issues we’ve touched on at Retraction Watch is what happens once papers are retracted. A few studies have found that other authors continue to cite those studies anyway, without noting their withdrawal from the literature. A more recent paper found that retractions are linked to a dramatic decline in citations (see last half of post). And we’ve reported on one case in which the authors of a retracted study decided not to cite it at all when they republished their findings elsewhere.
Have you seen this correction, from the September 8, 2011 issue of Nature, for “Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells?”
The figures and Supplementary figures of this Letter are affected by errors and improper editing. The correct figures are now provided, with an explanation of the variations. The original Letter has not been corrected online. We apologise for the confusion that our errors could have produced. We admit our negligence in the supervision of technical activity. We acknowledge that image manipulation is not acceptable and that any image modification must be clearly described. None of the alterations have any direct impact on the validity of our conclusions, which were also substantially confirmed in papers published by other independent groups1, 2. Continue reading We’re mostly wrong, but trust us: Our column on mega-corrections for Lab Times
The journal Inhalation Toxicology has issued a fascinating correction notice covering four articles on various aspects of asbestos exposure by a group of researchers who failed to note their connection to Georgia-Pacific, the industrial giant that became caught up in a deluge of costly lawsuits over the carcinogenic chemical during the 1980s.
A 60 Minutes segment Sunday on Anil Potti has drawn national attention to the case, so we thought this would be a good time to compile all of the retractions and corrections in one place.
Duke has said that about a third of Potti’s 40-some-odd papers would be retracted, and another third would have “a portion retracted with other components remaining intact,” so this list will continue to grow. We’ll update it as we hear about new changes.
Authors’ financial disclosures can be a thorny issue for scientific journals. There’s often confusion over just what should be listed as a conflict of interest, and when relationships are revealed after papers are published, lack of disclosure sometimes leads to corrections.